Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solution
SECTIONS
Last Updated: Dec 24, 2020, 07:04 PM IST
Share
Synopsis
The company has received tentative approval to market its Efinaconazole topical solution, 10%, from the United States Food and Drug Administration (USFDA), Lupin said in a regulatory filing.
Agencies
NEW DELHI: Drug firm
Lupin on Thursday said it has received tentative nod from the US health regulator to market generic Efinaconazole topical solution used for treatment of fungal infections of toenails.
The company has received tentative approval to market its Efinaconazole topical solution, 10%, from the United States Food and Drug Administration (USFDA), Lupin said in a regulatory filing.